Sigmoid Septum Diagnosis and Management

Definition and Clinical Significance

A sigmoid septum is a benign cardiac anatomical variant characterized by focal basal septal hypertrophy with increased angulation between the interventricular septum and ascending aorta, typically seen in elderly hypertensive patients, and does not routinely require referral to a specialist unless symptomatic left ventricular outflow tract obstruction develops, according to the European Society of Cardiology 1
The European Society of Cardiology recommends that a sigmoid septum represents isolated basal interventricular septal hypertrophy (≥13mm in men, ≥12mm in women) that exceeds 50% of the median septal thickness, creating an S-shaped or "bulging" appearance of the basal septum 1
The American Heart Association notes that this condition is generally benign with limited data suggesting individuals are less likely to have familial disease or sarcomeric protein gene mutations 1

The European Society of Cardiology states that sigmoid septum differs from true HCM in several critical ways, including ECG findings, which show normal or isolated voltage increases without marked repolarization abnormalities, unlike HCM which shows significant repolarization changes, conduction disease, or Q-waves 1
The American College of Cardiology notes that cardiac imaging also differs, with absence of right ventricular hypertrophy and different late gadolinium enhancement patterns on cardiac MRI (when present, enhancement in sigmoid septum differs from the RV insertion point pattern typical of HCM) 1
The European Society of Cardiology recommends that severity of dysfunction is also less severe, with less severe diastolic dysfunction compared to HCM 1

The American Heart Association advises that referral to a cardiologist (not neurologist) is appropriate for patients with exertional symptoms (dyspnea, chest pain, syncope) 1
The European Society of Cardiology recommends stress echocardiography with physiological provocation to assess for latent LVOT obstruction, performed similarly to HCM evaluation 1
The American College of Cardiology notes that medical management with beta-blockers (carvedilol) and calcium channel blockers (verapamil) is first-line therapy for symptomatic obstruction 1

The European Society of Cardiology states that family screening is generally not necessary for sigmoid septum, unlike true HCM, but advice should be guided by presence of suspicious symptoms in relatives and implications for family members if there is any diagnostic uncertainty 1

The American Heart Association warns against misdiagnosing as HCM, as sigmoid septum patients are older, hypertensive, with normal ECGs—regression with blood pressure control suggests hypertension rather than HCM 1
The European Society of Cardiology advises against overlooking symptomatic LVOT obstruction, and recommends always performing provocative testing in symptomatic patients, as resting echocardiography may appear normal 1
The American College of Cardiology notes that inappropriate neurological workup is not warranted, as this cardiac finding does not warrant neurological or neurosurgical evaluation 2, 3, 4, 5
The European Society of Cardiology recommends optimizing blood pressure, as hypertension management may reduce septal thickness over time 1